PD-LI Expression in a Non-Small Cell Lung Cancer Specimen Obtained by EBUS-TBNA

被引：0

作者：

Fernandez-Bussy, Sebastian ^{[1
]}

Pires, Yumay ^{[2
]}

Labarca, Gonzalo ^{[3
,4
]}

Vial, Macarena R. ^{[1
]}

机构：

[1] Univ Desarrollo, Clin Alemana Santiago, Unidad Neumol Intervencionista, Santiago, Chile

[2] Univ Desarrollo, Clin Alemana Santiago, Dept Anat Patol, Santiago, Chile

[3] Univ San Sebastian, Fac Med, Concepcion, Chile

[4] Complejo Asistencial Dr Victor Rios Ruiz, Dept Med Interna, Los Angeles, Chile

来源：

ARCHIVOS DE BRONCONEUMOLOGIA | 2018年 / 54卷 / 05期

关键词：

CHEMOTHERAPY; DOCETAXEL; NIVOLUMAB;

D O I：

10.1016/j.arbr.2017.10.019

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

引用

页码：290 / 292

页数：3

共 50 条

[31] Clinical values of different specimen preparation methods for the diagnosis of lung cancer by EBUS-TBNA
Wang, Hansheng
Wang, Jiankun
Liu, Yan
Wang, Yunyun
Zhou, Yanhui
Yu, Dan
You, Hui
Ren, Tao
Tang, Yijun
Wang, Meifang
DIAGNOSTIC PATHOLOGY, 2024, 19 (01)
[32] ROLE OF CONTRALATERAL HILAR NODE SAMPLING DURING NON-SMALL CELL LUNG CANCER SYSTEMATIC STAGING OF HILUM AND MEDIASTINUM WITH EBUS-TBNA
Rathunde, Lucas
Clinic, Cleveland
Leon, Carlos Aravena
Almeida, Francisco
CHEST, 2019, 156 (04) : 344A - 344A
[33] A multi-centre analysis of the performance of EBUS-TBNA testing for comprehensive molecular profiling in non-small cell lung cancer (NSCLC)
Dyer, Craig
Marshall, Kelly
Ghosal, Robin
Williams, Rhian
LUNG CANCER, 2024, 190
[34] How Many Passes Are Enough in EBUS-TBNA Procedures for Diagnostic Yield of Next Generation Sequencing in Non-small Cell Lung Cancer?
Dufour, M.
Rinfret, F.
Boily-Daoust, C.
Lemiere, C.
Brosseau, M.
Vandemoortele, T.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2024, 209
[35] RATE OF PATHOLOGIC UPSTAGING IN PATIENTS WITH CLINICAL N0 NON-SMALL CELL LUNG CANCER AFTER EBUS-TBNA STAGING
Ajmani, Gaurav
Ravikumar, Nakul
Murgu, Septimiu D.
CHEST, 2023, 164 (04) : 4196A - 4196A
[36] The Role of Lymph Node Staging by EBUS-TBNA in Stereotactic Body Radiation Therapy for patients with Non-Small Cell Lung Cancer.
Hashimoto, K.
Daddi, N.
Giuliani, M.
Hope, A.
Le, L.
Czarnecka, K.
Cypel, M.
Pierre, A.
De Perrot, M.
Darling, G.
Waddell, T.
Keshavjee, S.
Yasufuku, K.
JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2031 - S2032
[37] PERFORMANCE OF EBUS-TBNA IN THE PATHOLOGICAL SUBTYPING AND MOLECULAR TESTING OF NON-SMALL CELL LUNG CANCER (NSCLC) IN A UK THORACIC ONCOLOGY CENTRE
Al-Najjar, H.
Evison, M.
Martin, J.
Barber, P.
Crosbie, P.
Booton, R.
THORAX, 2015, 70 : A24 - A24
[38] EBUS-TBNA as a Promising Method for the Evaluation of Tumor PD-L1 Expression in Lung Cancer
Sakakibara, Rie
Inamura, Kentaro
Tambo, Yuichi
Ninomiya, Hironori
Kitazono, Satoru
Yanagitani, Noriko
Horiike, Atsushi
Ohyanagi, Fumiyoshi
Matsuura, Yosuke
Nakao, Masayuki
Mun, Mingyon
Okumura, Sakae
Inase, Naohiko
Nishio, Makoto
Motoi, Noriko
Ishikawa, Yuichi
CLINICAL LUNG CANCER, 2017, 18 (05) : 527 - +
[39] Feasibility of EBUS-TBNA specimens for PD-L1 expression test in lung cancer.
Tambo, Yuichi
Sakakibara, Rie
Motoi, Noriko
Ohyanagi, Fumiyoshi
Kitazono, Satoru
Horiike, Atsushi
Yanagitani, Noriko
Oguri, Tomoyo
Kawashima, Yosuke
Takano, Natsuki
Ishikawa, Yuichi
Nishio, Makoto
JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
[40] Heterogeneity analysis of PD-L1 expression and copy number status in EBUS-TBNA biopsy specimens of non-small cell lung cancer: Comparative assessment of primary and metastatic sites
Yoshimura, Katsuhiro
Inoue, Yusuke
Karayama, Masato
Tsuchiya, Kazuo
Mori, Kazutaka
Suzuki, Yuzo
Iwashita, Yuji
Kahyo, Tomoaki
Kawase, Akikazu
Tanahashi, Masayuki
Ogawa, Hiroshi
Yokomura, Koushi
Inui, Naoki
Funai, Kazuhito
Shinmura, Kazuya
Niwa, Hiroshi
Suda, Takafumi
Sugimura, Haruhiko
LUNG CANCER, 2019, 134 : 202 - 209

← 1 2 3 4 5 →